deoxyglucose has been researched along with Diabetic Retinopathy in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (21.43) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Alouffi, S; Khan, MWA | 1 |
Aiello, LP; Avery, RL; Clermont, AC; Feener, EP; Fickweiler, W; Hernandez, SL; Ishikado, A; Katagiri, S; Keenan, HA; Kern, TS; King, GL; Li, Q; Maeda, Y; Paniagua, SM; Park, K; Pober, DM; Simao, F; Sun, B; Sun, JK; Tinsley, LJ; Wang, CH; Wu, IH; Yokomizo, H | 1 |
Coresh, J; Grams, M; Klein, R; Rawlings, AM; Selvin, E; Steffes, M | 1 |
Lawler, PR; Mora, S | 1 |
Jeon, WS; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ | 1 |
Fokkens, BT; Los, LI; Mulder, DJ; Schalkwijk, CG; Scheijen, JL; Smit, AJ | 1 |
Ambrósio, AF; Carvalho, RA; Cristóvão, AJ; Duarte, JM; Garrido, MJ; Santiago, AR | 1 |
Ahn, HY; Kim, SW; Kim, WJ; Kim, YJ; Lee, WY; Oh, KW; Park, CY; Park, HS; Park, SE; Park, SW; Rhee, EJ; Song, SJ | 1 |
Inaba, K; Kasuga, M; Kojima, H; Kusunoki, H; Liu, BF; Miyata, S; Miyazaki, H; Ohara, T; Suzuki, K; Uriuhara, A; Yamashita, Y | 1 |
Akanuma, H; Ichiyanagi, K; Kawasaki, T; Ogata, N; Sakai, T; Watanabe, H; Yamanouchi, T | 1 |
Feinendegen, LE; Gries, FA; Herzog, H; Kuwert, T; Langen, KJ; Mühlen, H; Ziegler, D | 1 |
Bretzel, RG; Brownlee, M; Hammes, HP; Lin, J; Schleicher, E | 1 |
Akanuma, Y | 1 |
Hamada, Y; Horiuchi, S; Hotta, N; Kasuya, Y; Kato, K; Komori, T; Nagai, R; Nakamura, J; Naruse, K | 1 |
2 review(s) available for deoxyglucose and Diabetic Retinopathy
Article | Year |
---|---|
Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
Topics: Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Insulin; Insulin Resistance; Isoenzymes; Lactoylglutathione Lyase; Oxidative Stress; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
[Physiopathology and therapy of diabetes mellitus].
Topics: Animals; Arteriosclerosis; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Insulin Resistance; Obesity; Patient Education as Topic | 1999 |
12 other study(ies) available for deoxyglucose and Diabetic Retinopathy
Article | Year |
---|---|
Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy.
Topics: 3-O-Methylglucose; Acids; Animals; Cell Movement; Deoxyglucose; Diabetes Mellitus; Diabetic Retinopathy; Endothelial Cells; Ependymoglial Cells; Eye Proteins; Glycolysis; Humans; Intravitreal Injections; Mice, Inbred C57BL; Mice, Transgenic; Photoreceptor Cells, Vertebrate; Protective Agents; Protein Domains; Rats, Inbred Lew; Recombinant Proteins; Reproducibility of Results; Retina; Retinol-Binding Proteins; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vitreous Body | 2019 |
Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.
Topics: Cohort Studies; Deoxyglucose; Diabetes Mellitus; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Renal Insufficiency, Chronic; ROC Curve | 2014 |
Moving beyond mean glycemia: 1,5-anhydroglucitol and microvascular complications of diabetes.
Topics: Deoxyglucose; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans; Hyperglycemia; Male; Renal Insufficiency, Chronic | 2014 |
The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus.
Topics: Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Republic of Korea; Serum Albumin | 2016 |
Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Retinal Detachment | 2017 |
Evaluation of the impact of diabetes on retinal metabolites by NMR spectroscopy.
Topics: Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucose; Glycolysis; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Wistar; Retina | 2010 |
Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes.
Topics: Albuminuria; Biomarkers; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Logistic Models; Male; Middle Aged; Prevalence; Republic of Korea; Risk Factors | 2012 |
Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Biomarkers; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Fasting; Glycated Hemoglobin; Glycosylation; Humans; Middle Aged; Platelet Activating Factor; Reference Values | 2003 |
Postprandial plasma fructose level is associated with retinopathy in patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Fructose; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period; Prevalence | 2004 |
Cerebral glucose metabolism in type 1 diabetic patients.
Topics: Adult; Blood Glucose; Brain; Brain Stem; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diabetic Retinopathy; Evoked Potentials, Auditory; Evoked Potentials, Visual; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Motor Neurons; Neural Conduction; Neurons, Afferent; Reference Values; Time Factors | 1994 |
Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Leukocyte Common Antigens; Lysine; Male; Middle Aged; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyruvaldehyde; Risk Factors; T-Lymphocytes | 1999 |
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Topics: Aldehyde Reductase; Blood Glucose; Blood Proteins; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Reference Values; Rhodanine; Thiazolidines | 2000 |